Literature DB >> 12853208

Potential for receptor-based antiviral drugs against SARS.

Richard K Williams, Curtis L Yeager, Kathryn V Holmes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12853208      PMCID： PMC7134702          DOI： 10.1016/S0140-6736(03)13818-4

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  Receptor for mouse hepatitis virus is a member of the carcinoembryonic antigen family of glycoproteins.

Authors:  R K Williams; G S Jiang; K V Holmes
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-01       Impact factor: 11.205

2.  Monoclonal antibody to the receptor for murine coronavirus MHV-A59 inhibits viral replication in vivo.

Authors:  A L Smith; C B Cardellichio; D F Winograd; M S de Souza; S W Barthold; K V Holmes
Journal:  J Infect Dis       Date:  1991-04       Impact factor: 5.226

3.  Determinants essential for the transmissible gastroenteritis virus-receptor interaction reside within a domain of aminopeptidase-N that is distinct from the enzymatic site.

Authors:  B Delmas; J Gelfi; E Kut; H Sjöström; O Noren; H Laude
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

4.  Aminopeptidase N inhibitors and SARS.

Authors:  Dimitrios P Kontoyiannis; Renata Pasqualini; Wadih Arap
Journal:  Lancet       Date:  2003-05-03       Impact factor: 79.321

5.  Human aminopeptidase N is a receptor for human coronavirus 229E.

Authors:  C L Yeager; R A Ashmun; R K Williams; C B Cardellichio; L H Shapiro; A T Look; K V Holmes
Journal:  Nature       Date:  1992-06-04       Impact factor: 49.962
  5 in total
  3 in total

1.  Molecular modelling of S1 and S2 subunits of SARS coronavirus spike glycoprotein.

Authors:  Ottavia Spiga; Andrea Bernini; Arianna Ciutti; Stefano Chiellini; Nicola Menciassi; Francesca Finetti; Vincenza Causarono; Francesca Anselmi; Filippo Prischi; Neri Niccolai
Journal:  Biochem Biophys Res Commun       Date:  2003-10-10       Impact factor: 3.575

2.  Potential targets for anti-SARS drugs in the structural proteins from SARS related coronavirus.

Authors:  Guang Wu; Shaomin Yan
Journal:  Peptides       Date:  2004-06       Impact factor: 3.750

Review 3.  Detection of cytotoxic CD13-specific autoantibodies in sera from patients with ulcerative colitis and Crohn's disease.

Authors:  A Rahbar; L Boström; C Söderberg-Naucler
Journal:  J Autoimmun       Date:  2006-04-11       Impact factor: 7.094
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.